Delivery Order SPE2DB20D1100-SPE2DB25FE1JE
- Not listed
- The Defense Logistics Agency awarded a $9,280.01 delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Prezcobix 800 mg-150 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by June 18, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $5,282.14 to AmerisourceBergen Drug Corp for the supply of Prezcobix 800 mg-150 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg in units of 30 tablets, with a ceiling value of $1,787.67. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 9, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 8, 2025, to supply Prezista 800 mg tablets (30-count units) to the Defense Logistics Agency's Medical Supply Chain. The contract is valued at approximately $12.7K under firm fixed pricing with a completion date of September 9, 2025. This award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery...
- The U.S. Department of Defense Medical Supply Chain awarded a $20,959.22 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (quantity 30 units). This competitive, non-set-aside contract features firm fixed pricing and carries an ultimate completion date of June 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. The award represents a child order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Prezista 800 mg tablets in quantities of 30 units. This is a firm fixed price contract with a ceiling value of $36,612.01 and an ultimate completion date of August 4, 2025. The contract is not set-aside and represents a competitively awarded delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $38,749.42 for the supply of DESCOVY 200-25 mg tablets (30-count units) under a firm fixed-price contract with the Department of Defense Medical Supply Chain. The award was made on September 23, 2025, with an ultimate completion date of September 24, 2025, and represents a competitively awarded, non-set-aside procurement. This delivery order is a child contract issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 28, 2025, valued at $37,182.02. The contract calls for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Prezista 600 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $52,358.63. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Prezista 800 mg tablets in a 30-count quantity, with a ceiling value of $1,411.83. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1JEDelivery Order
The Defense Logistics Agency awarded a $57,765.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Prezco bix 800 mg-150 mg tablets (30-count) on September 26, 2025, with completion scheduled for September 29, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive IDC portfolio. The company's federal contract awards demonstrate consistent capability to deliver brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This award of antiretroviral medication reflects AmerisourceBergen's ongoing role in supporting the Department of Defense's pharmaceutical supply chain and military medical readiness initiatives through competitive procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $57.8k | 9/26/25 |